Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125876471 | 12587647 | 1 | I | 20160606 | 20160607 | 20160725 | 20160725 | EXP | JP-JNJFOC-20160610135 | JANSSEN | 73.00 | YR | E | F | Y | 65.00000 | KG | 20160725 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125876471 | 12587647 | 1 | SS | DOXIL | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | Y | N | 0 | 40 | MG/M**2 | LIPOSOME INJECTION | QD | |||||
| 125876471 | 12587647 | 2 | PS | DOXIL | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | Y | N | 50718 | 40 | MG/M**2 | LIPOSOME INJECTION | QD | |||||
| 125876471 | 12587647 | 3 | C | TRICHLORMETHIAZIDE | TRICHLORMETHIAZIDE | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 125876471 | 12587647 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 125876471 | 12587647 | 5 | C | RABEPRAZOLE NA | RABEPRAZOLE SODIUM | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 125876471 | 12587647 | 6 | C | OLMETEC | OLMESARTAN MEDOXOMIL | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 125876471 | 12587647 | 7 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 125876471 | 12587647 | 8 | C | CELTOL | 2 | Intravenous (not otherwise specified) | 0 | 10 | MG | INJECTION | QD | ||||||||
| 125876471 | 12587647 | 9 | C | CELTOL | 2 | Intravenous (not otherwise specified) | 0 | 10 | MG | INJECTION | QD | ||||||||
| 125876471 | 12587647 | 10 | C | METFORMIN HYDROCHLORIDE. | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 125876471 | 12587647 | 11 | C | DECADRON | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 0 | 6.6 | MG | INJECTION | QD | |||||||
| 125876471 | 12587647 | 12 | C | DECADRON | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 0 | 6.6 | MG | INJECTION | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125876471 | 12587647 | 1 | Malignant peritoneal neoplasm |
| 125876471 | 12587647 | 2 | Ovarian cancer |
| 125876471 | 12587647 | 8 | Malignant peritoneal neoplasm |
| 125876471 | 12587647 | 9 | Ovarian cancer |
| 125876471 | 12587647 | 11 | Malignant peritoneal neoplasm |
| 125876471 | 12587647 | 12 | Ovarian cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125876471 | 12587647 | OT |
| 125876471 | 12587647 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125876471 | 12587647 | Anaphylactic reaction | |
| 125876471 | 12587647 | Blood pressure decreased | |
| 125876471 | 12587647 | Cyanosis | |
| 125876471 | 12587647 | Oxygen saturation decreased | |
| 125876471 | 12587647 | Vomiting | |
| 125876471 | 12587647 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125876471 | 12587647 | 1 | 20160606 | 20160606 | 0 | |
| 125876471 | 12587647 | 2 | 20160606 | 20160606 | 0 | |
| 125876471 | 12587647 | 8 | 20160606 | 20160606 | 0 | |
| 125876471 | 12587647 | 9 | 20160606 | 20160606 | 0 | |
| 125876471 | 12587647 | 11 | 20160606 | 20160606 | 0 | |
| 125876471 | 12587647 | 12 | 20160606 | 20160606 | 0 |